文献速递造血干细胞移植与细胞治疗

慢性移植物抗宿主病关节/筋膜受累的NIH应答算法优化

Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia.
PubMed 文献 · Blood Adv · 2020-01-01

基于慢性GVHD联盟多中心前瞻性观察数据,训练队列209例、复制队列191例关节/筋膜受累患者,采用线性混合模型评估应答分类与医患感知关节状态变化的相关性。结果显示总P-ROM评分2分变化有临床意义,NIH关节/筋膜评分0→1不应视为恶化,仅总P-ROM评分(而非单个关节P-ROM)用于应答评估。据此开发优化算法,约40%应答被重新分类,主要消除了单个关节间分歧及0→1变化的影响,且与医患感知变化的关联更稳健。

要点

  • NIH关节/筋膜评分0→1不应视为恶化。
  • 总P-ROM评分2分变化具有临床意义。
  • 应答评估应采用NIH评分与总P-ROM评分,而非单个P-ROM评分。

核心结论

  • 优化算法为关节/筋膜慢性GVHD提供更优的循证疗效评估方法。
  • 优化算法较2014版NIH算法与医患感知变化关联更稳健。

研究设计与样本

  • 多中心前瞻性观察研究,训练队列209例、复制队列191例慢性GVHD关节/筋膜受累患者。
  • 采用随机患者效应的线性混合模型评估应答分类与医患感知关节状态变化的相关性。

主要发现

  • 训练队列分析显示总P-ROM评分2分变化具有临床意义。
  • NIH关节/筋膜评分0→1不应视为恶化。
  • 应使用NIH关节/筋膜评分和总P-ROM评分进行应答评估,而非单个P-ROM评分。
  • 优化算法使约40%的应答被重新分类,主要消除了单个关节间分歧及NIH评分0→1变化的影响。
  • 优化算法显示稳健的点估计和更紧的95%置信区间。

关键数值与推荐

  • 总P-ROM评分变化2分作为临床有意义阈值。
  • NIH关节/筋膜评分从0变为1不判定为恶化。
  • 应答评估采用NIH关节/筋膜评分与总P-ROM评分,不采用单个P-ROM评分。

临床怎么用

  • 临床评估关节/筋膜慢性GVHD疗效时,应采用优化算法,避免将NIH评分0→1判为恶化。
  • 应关注总P-ROM评分变化而非单个关节P-ROM评分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Implementation of the 2014 National Institutes of Health (NIH) response algorithm for joint/fascia graft-versus-host disease (GVHD) has identified real-world limits to its application. To refine the 2014 NIH response algorithm, we analyzed multicenter prospective observational data from the Chronic GVHD Consortium. The training cohort included 209 patients and the replication cohort included 191 patients with joint/fascia involvement during their course of chronic GVHD. Linear mixed models with random patient effect were used to evaluate correlations between response categories and clinician- or patient-perceived changes in joint status as an anchor of response. Analysis of the training cohort showed that a 2-point change in total photographic range of motion (P-ROM) score was clinically meaningful. The results also suggested that a change from 0 to 1 on the NIH joint/fascia score should not be considered as worsening and suggested that both the NIH joint/fascia score and total P-ROM score, but not individual P-ROM scores, should be used for response assessment. On the basis of these results, we developed an evidence-based refined algorithm, the utility of which was examined in an independent replication cohort. Using the refined algorithm, ∼40% of responses were reclassified, largely mitigating most divergent responses among individual joints and changes from 0 to 1 on the NIH joint/fascia score. The refined algorithm showed robust point estimates and tighter 95% confidence intervals associated with clinician- or patient-perceived changes, compared with the 2014 NIH algorithm. The refined algorithm provides a superior, evidence-based method for measuring therapeutic response in joint/fascia chronic GVHD.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Inamoto Y, Lee SJ, Onstad LE, et al. Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia. Blood Adv. 2020. PMID: 31899796. doi:10.1182/bloodadvances.2019000918

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。